Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
71
BCLYF Quote, Financials, Valuation and Earnings
Last price:
$4.72
Seasonality move
:
1.52%
Day range:
$4.68 - $4.83
52-week range:
$2.54 - $4.77
Dividend yield:
2.31%
P/E ratio:
9.39x
P/S ratio:
1.97x
P/B ratio:
0.68x
Volume:
228.9K
Avg. volume:
61.9K
1-year change:
60.87%
Market cap:
$65.5B
Revenue:
$33.5B
EPS (TTM):
$0.49
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $27.7B | $30.2B | $31B | $31.6B | $33.5B | |
| Revenue Growth (YoY) | 0.47% | 8.87% | 2.59% | 1.94% | 6.13% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.6B | $2.7B | $2.8B | $3.2B | $3.5B | |
| Other Inc / (Exp) | -$30.8M | $400.3M | -$484.2M | $75.9M | $553.4M | |
| Operating Expenses | $17.2B | $18.7B | $18.7B | $18.7B | $20.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $3.9B | $11.3B | $8.7B | $8.2B | $10.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $775.2M | $1.6B | $1.3B | $1.5B | $2.2B | |
| Net Income to Company | $3.9B | $11.3B | $8.7B | $8.2B | $10.4B | |
| Minority Interest in Earnings | -$100.1M | -$64.7M | -$55.7M | -$79.6M | -$62.6M | |
| Net Income to Common Excl Extra Items | $3.1B | $9.6B | $7.3B | $6.5B | $8.1B | |
| Basic EPS (Cont. Ops) | $0.11 | $0.50 | $0.38 | $0.34 | $0.46 | |
| Diluted EPS (Cont. Ops) | $0.11 | $0.49 | $0.37 | $0.33 | $0.44 | |
| Weighted Average Basic Share | $17.3B | $17B | $16.3B | $15.4B | $14.8B | |
| Weighted Average Diluted Share | $17.7B | $17.4B | $16.9B | $15.9B | $15.3B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $8.8B | $15.6B | $19.2B | $36B | $42.8B | |
| Revenue (Reported) | $27.7B | $30.2B | $31B | $31.6B | $33.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $8.8B | $15.6B | $19.2B | $36B | $42.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.1B | $8.7B | $8.8B | $8.8B | $9.7B | |
| Revenue Growth (YoY) | 0.99% | 7.16% | 0.93% | 0.26% | 10.06% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $4.9B | $4.8B | $5B | $5.2B | $5.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $3.3B | $3B | $3.2B | $2.9B | $3.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $683.7M | $823.8M | $681.9M | $589.8M | $781.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$5.5M | -$1.3M | -$9.7M | -$3.8M | -$2.5M | |
| Net Income to Common Excl Extra Items | $2.6B | $2.2B | $2.5B | $2.3B | $2.6B | |
| Basic EPS (Cont. Ops) | $0.14 | $0.11 | $0.14 | $0.13 | $0.16 | |
| Diluted EPS (Cont. Ops) | $0.14 | $0.11 | $0.14 | $0.13 | $0.16 | |
| Weighted Average Basic Share | $17.3B | $16.7B | $15.8B | $15B | $14.3B | |
| Weighted Average Diluted Share | $17.3B | $16.7B | $15.8B | $15B | $14.3B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.3B | $3B | $3.2B | $2.9B | $3.4B | |
| Revenue (Reported) | $8.1B | $8.7B | $8.8B | $8.8B | $9.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.3B | $3B | $3.2B | $2.9B | $3.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $27.8B | $30.8B | $31.1B | $31.6B | $34.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $18B | $18.1B | $18.8B | $18.8B | $20.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $6.1B | $11.1B | $8.9B | $7.9B | $10.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.4B | $1.7B | $1.2B | $1.4B | $2.4B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$85.5M | -$60.1M | -$63.1M | -$73.8M | -$61M | |
| Net Income to Common Excl Extra Items | $4.6B | $9.3B | $7.6B | $6.4B | $8.4B | |
| Basic EPS (Cont. Ops) | $0.20 | $0.49 | $0.41 | $0.34 | $0.49 | |
| Diluted EPS (Cont. Ops) | $0.20 | $0.48 | $0.41 | $0.33 | $0.49 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $6.1B | $11.1B | $8.9B | $7.9B | $10.9B | |
| Revenue (Reported) | $27.8B | $30.8B | $31.1B | $31.6B | $34.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $6.1B | $11.1B | $8.9B | $7.9B | $10.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.1B | $8.7B | $8.8B | $8.8B | $9.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $4.9B | $4.8B | $5B | $5.2B | $5.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $3.3B | $3B | $3.2B | $2.9B | $3.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $683.7M | $823.8M | $681.9M | $589.8M | $781.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$5.5M | -$1.3M | -$9.7M | -$3.8M | -$2.5M | |
| Net Income to Common Excl Extra Items | $2.6B | $2.2B | $2.5B | $2.3B | $2.6B | |
| Basic EPS (Cont. Ops) | $0.14 | $0.11 | $0.14 | $0.13 | $0.16 | |
| Diluted EPS (Cont. Ops) | $0.14 | $0.11 | $0.14 | $0.13 | $0.16 | |
| Weighted Average Basic Share | $17.3B | $16.7B | $15.8B | $15B | $14.3B | |
| Weighted Average Diluted Share | $17.3B | $16.7B | $15.8B | $15B | $14.3B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.3B | $3B | $3.2B | $2.9B | $3.4B | |
| Revenue (Reported) | $8.1B | $8.7B | $8.8B | $8.8B | $9.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.3B | $3B | $3.2B | $2.9B | $3.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $260.5B | $322B | $310.2B | $286.2B | $263.7B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $873.2B | $876.8B | $876.9B | $806.8B | $816.1B | |
| Property Plant And Equipment | $5.5B | $4.8B | $4.4B | $4.4B | $4.5B | |
| Long-Term Investments | $724.7B | $674.7B | $658B | $710B | $749.5B | |
| Goodwill | $5.3B | $5.3B | $4.7B | $5.3B | $5.6B | |
| Other Intangibles | $5.5B | $5.6B | $5.2B | $4.6B | $4.8B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.8T | $1.9T | $1.8T | $1.9T | $1.9T | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $5.6B | $7.4B | $10.2B | $9.1B | $6.8B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.7T | $1.8T | $1.7T | $1.8T | $1.8T | |
| Common Stock | $5.9B | $5.7B | $4.8B | $4.8B | $4.5B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $89.7B | $93.2B | $82.6B | $90.7B | $90.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.5B | $1.3B | $1.2B | $840.8M | $828.2M | |
| Total Equity | $91.1B | $94.5B | $83.8B | $91.5B | $90.9B | |
| Total Liabilities and Equity | $1.8T | $1.9T | $1.8T | $1.9T | $1.9T | |
| Cash and Short Terms | $260.5B | $322B | $310.2B | $286.2B | $263.7B | |
| Total Debt | $196.3B | $224.8B | $221.9B | $224.9B | $233.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $288B | $348B | $329.3B | $317.2B | $309.8B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $674.5B | $733.1B | $649.5B | $637.9B | $650.5B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $933.5B | $912B | $880B | $1T | $1T | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.9T | $2T | $1.9T | $2T | $2.1T | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.1B | $1.4B | $696M | $820.6M | $1.2B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.8T | $1.9T | $1.8T | $1.9T | $2T | |
| Common Stock | $6.3B | $6B | $5.4B | $5.4B | $5.5B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.5B | $1.3B | $1.2B | $833.3M | $853.8M | |
| Total Equity | $91B | $91.2B | $87.5B | $91.3B | $97.7B | |
| Total Liabilities and Equity | $1.9T | $2T | $1.9T | $2T | $2.1T | |
| Cash and Short Terms | $288B | $348B | $329.3B | $317.2B | $309.8B | |
| Total Debt | $141.9B | $160.6B | $156.9B | $150B | $143B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.9B | $11.3B | $8.7B | $8.2B | $10.4B | |
| Depreciation & Amoritzation | $2.2B | $2.3B | $2.1B | $2.2B | $2.2B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $73.8B | $67.3B | $37.4B | -$1.2B | $9.1B | |
| Capital Expenditures | $1.7B | $2.4B | $2.2B | $2.1B | $2B | |
| Cash Acquisitions | -- | $1.5B | -- | -$3B | -$587.9M | |
| Cash From Investing | -$23.6B | $5.9B | -$26.8B | -$29.1B | -$22.9B | |
| Dividends Paid (Ex Special Dividend) | -$1.2B | -$1.9B | -$2.4B | -$2.8B | -$2.9B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $9.2B | $14.2B | $15.6B | $14.1B | $17.9B | |
| Long-Term Debt Repaid | -$4.2B | -$11.4B | -$11.2B | -$10.6B | -$9.7B | |
| Repurchase of Common Stock | -$1.8B | -$2.3B | -$5.1B | -$6.5B | -$6.4B | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $3.5B | $147.2M | $861.9M | -$1.7B | $1B | |
| Beginning Cash (CF) | $213.8B | $289.1B | $321B | $346.9B | $317B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $53.7B | $73.3B | $11.5B | -$32B | -$12.8B | |
| Ending Cash (CF) | $269.7B | $356.6B | $345.2B | $308.6B | $301.1B | |
| Levered Free Cash Flow | $72.1B | $64.9B | $35.3B | -$3.3B | $7.1B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.6B | $6.9B | $4.7B | $5.7B | $5.3B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $68.4B | $54.4B | $78.3B | $29.9B | $47.4B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$22.1B | -$4.7B | -$18.8B | -$18.5B | -$20.6B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $3.9B | -$3.6B | -$6.9B | -$239.1M | $209.4M | |
| Beginning Cash (CF) | $206.6B | $293.7B | $325.9B | $349B | $312.9B | |
| Foreign Exchange Rate Adjustment | $9.7B | -$7.7B | $8.9B | -$7.6B | -$2B | |
| Additions / Reductions | $50.2B | $46.1B | $52.6B | $11.2B | $27B | |
| Ending Cash (CF) | $266.5B | $332.1B | $387.3B | $352.5B | $337.9B | |
| Levered Free Cash Flow | $68.4B | $54.4B | $78.3B | $29.9B | $47.4B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $118.7B | $128.5B | $204.9B | $231B | $210B | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.9B | $4.7B | $5.7B | $5.3B | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $54.4B | $78.3B | $29.9B | $47.4B | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$4.7B | -$18.8B | -$18.5B | -$20.6B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$3.6B | -$6.9B | -$239.1M | $209.4M | -- | |
| Beginning Cash (CF) | $293.7B | $325.9B | $349B | $312.9B | -- | |
| Foreign Exchange Rate Adjustment | -$7.7B | $8.9B | -$7.6B | -$2B | -- | |
| Additions / Reductions | $46.1B | $52.6B | $11.2B | $27B | -- | |
| Ending Cash (CF) | $332.1B | $387.3B | $352.5B | $337.9B | -- | |
| Levered Free Cash Flow | $54.4B | $78.3B | $29.9B | $47.4B | -- | |
Get BCLYF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BCLYF
Sector
P/E ratio
9.39x
12.18x
PEG ratio
0.20x
0.40x
P/B ratio
0.68x
1.10x
Price / LTM sales
1.97x
2.66x
Growth Metrics
BCLYF
Sector
Revenue growth
10.06%
5.1%
Earnings growth
25.29%
2.61%
Revenue (5-year growth)
3.96%
5.17%
Earnings forecast
--
$0.61
Profitability
BCLYF
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
3.32%
5.2%
Return on assets
0.42%
0.97%
Return on equity
9.01%
9.24%
Earnings Date
Last Earnings Date
Apr
30
Next Earnings Date
Jul
29
Estimated Next Earnings Date
Jul
30
Balance Sheet
BCLYF
Sector
Total cash
$309.8B
$452M
Short term investments
--
$220.9M
Total assets
$1.9T
$3.8B
Long term debt
$143B
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
